Marcus and Millichap reported a notable increase in revenue for the fourth quarter of 2024, reaching $240 million, marking a 44% year-over-year growth. The company's full-year revenue also rose to ...

The off-the-shelf chimeric antigen receptor T-cell therapy P-BCMA-ALLO1 was shown to be safe and elicited strong anti-tumor ...

Patients Achieved Remission Within 30 Days in Cohort 1 of the Mipletamig RAINIER Dose Optimization Trial for Frontline AML Patients, Trial Enrollment Continues Promising Data, including a 59% Stable ...

Said, S. (2025) The Impact of Capital Structure on Firm Performance: Empirical Evidence from Egypt. Open Access Library Journal, 12, 1-16. doi: 10.4236/oalib.1112839 .